BMC Business

BioMedCore has 13 Pipelines and following 3 Pipelines are active.

(1)BMC-007 For Anticancer Drug

Liposome preparation for Generic Drug of DOXIL.

Finished initial study and waiting next stage.

(2)BMC-010 For Posterior Segment Inflammatory Diseases

Liposome preparation could be replaced with Injection.

Under preclinical test.

(3)BMC-011 For Myocardial Reperfusion Injury

Research and development would start from next spring.